Clinical Trial Update: Connective Tissue Motion Measure 2

View source ↗

Summary

The Connective Tissue Motion Measure 2 trial sponsored by Stromatec, Inc. has completed, studying low back pain and musculoskeletal pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Musculoskeletal Pain

Snippet

Sponsor: Stromatec, Inc. | Conditions: Low Back Pain, Musculoskeletal Pain | Status: COMPLETED